ConductScience.org, home

Paper28220118

Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.

Mizrahy S and 4 others. Front Immunol, 2017. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles. Papers, record 28220118. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28220118

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.
PubMed
Journal
Front Immunol
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2019-11-20
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mizrahy SShoshy
2Hazan-Halevy IInbal
3Landesman-Milo DDalit
4Ng BDBrandon D
5Peer DDan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123113570Anti-tumour strategies aiming to target tumour-associated macrophages.Immunology2013https://conductscience.org/library/papers/23113570PubMed
221576818Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.J Clin Invest2011https://conductscience.org/library/papers/21576818PubMed
312604051Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.J Liposome Res2002https://conductscience.org/library/papers/12604051PubMed
410688625Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.J Pharmacol Exp Ther2000https://conductscience.org/library/papers/10688625PubMed
525413851siRNA nanoparticles: the future of RNAi therapeutics for oncology?Nanomedicine (Lond)2014https://conductscience.org/library/papers/25413851PubMed
622437869Combining immunotherapy and targeted therapies in cancer treatment.Nat Rev Cancer2012https://conductscience.org/library/papers/22437869PubMed
721983520Therapeutic siRNA silencing in inflammatory monocytes in mice.Nat Biotechnol2011https://conductscience.org/library/papers/21983520PubMed
88080272Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing.Arch Biochem Biophys1994https://conductscience.org/library/papers/8080272PubMed
923774794Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.Mol Ther2013https://conductscience.org/library/papers/23774794PubMed
1019632178CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.Cell2009https://conductscience.org/library/papers/19632178PubMed
1118654426Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol2007https://conductscience.org/library/papers/18654426PubMed
1227235608Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach.Cancer Lett2016https://conductscience.org/library/papers/27235608PubMed
1317873867Exploiting lymphatic transport and complement activation in nanoparticle vaccines.Nat Biotechnol2007https://conductscience.org/library/papers/17873867PubMed
1417875754Transforming growth factor-beta and the immune response: implications for anticancer therapy.Clin Cancer Res2007https://conductscience.org/library/papers/17875754PubMed
1525022906Non-viral vectors for gene-based therapy.Nat Rev Genet2014https://conductscience.org/library/papers/25022906PubMed
1627775706Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses.Nat Med2016https://conductscience.org/library/papers/27775706PubMed
1725287120Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery.Nat Rev Drug Discov2014https://conductscience.org/library/papers/25287120PubMed
1821336265Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses.Nat Mater2011https://conductscience.org/library/papers/21336265PubMed
1925558928Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.ACS Nano2015https://conductscience.org/library/papers/25558928PubMed
2017065229Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.FASEB J2006https://conductscience.org/library/papers/17065229PubMed

See all 63 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
40860882Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy.Front Pharmacol2025https://conductscience.org/library/papers/40860882PubMed
40746220Physicochemical Characterization, Drug Release, Stability, and Cytotoxicity of Cross-Linked Curdlan-Based Nanosponges for α-Amyrin and Higenamine Delivery.Turk J Pharm Sci2025https://conductscience.org/library/papers/40746220PubMed
40379943Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation.Clin Exp Med2025https://conductscience.org/library/papers/40379943PubMed
40124335For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy.Mater Today Bio2025https://conductscience.org/library/papers/40124335PubMed
37289328Adipocyte-derived extracellular vesicles: bridging the communications between obesity and tumor microenvironment.Discov Oncol2023https://conductscience.org/library/papers/37289328PubMed
36012619Lipid Nanoparticles: Promising Treatment Approach for Parkinson's Disease.Int J Mol Sci2022https://conductscience.org/library/papers/36012619PubMed
34063088Nanotechnology in Bladder Cancer: Diagnosis and Treatment.Cancers (Basel)2021https://conductscience.org/library/papers/34063088PubMed
32440473Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer.Adv Sci (Weinh)2020https://conductscience.org/library/papers/32440473PubMed
32210954Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy.Front Immunol2020https://conductscience.org/library/papers/32210954PubMed
32172351Immune cell engineering: opportunities in lung cancer therapeutics.Drug Deliv Transl Res2020https://conductscience.org/library/papers/32172351PubMed
31218707Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines.Electrophoresis2019https://conductscience.org/library/papers/31218707PubMed
30926812Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma.Nat Commun2019https://conductscience.org/library/papers/30926812PubMed
30863514Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material.J Extracell Vesicles2019https://conductscience.org/library/papers/30863514PubMed
29670528Targeting Accessories to the Crime: Nanoparticle Nucleic Acid Delivery to the Tumor Microenvironment.Front Pharmacol2018https://conductscience.org/library/papers/29670528PubMed
29391232Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.J Control Release2018https://conductscience.org/library/papers/29391232PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28220118

GET https://conductscience.org/api/papers/v1/28220118/references?page=2